Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

This study has been completed.

Study NCT00522145 Information provided by Kadmon Corporation, LLC

First Received: August 27, 2007 Last Updated: January 24, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: January 24, 2012